检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:董俊红[1] 王振明[2] 付新华[1] 王守训[1] 黄焕生[1]
机构地区:[1]潍坊医学院生化教研室,山东潍坊261042 [2]潍坊市人民医院检验科,山东潍坊261041
出 处:《中国药理学通报》2009年第5期589-592,共4页Chinese Pharmacological Bulletin
基 金:山东省自然科学基金青年基金资助项目(NoQ2006D08)
摘 要:目的观察靶向survivin基因的短发夹RNA(shorthairpin RNA,shRNA)对人肺腺癌细胞A549生物学行为及紫杉醇敏感性的影响。方法将靶向survivin的基因片段插入载体后构建重组质粒,用转染试剂FuGENE(HD将其导入A549细胞,RT-PCR及Western blot分析转染前后survivin基因的表达情况,TUNEL法检测细胞凋亡情况,MTT法检测转染后A549细胞对紫杉醇的敏感性变化。结果成功构建重组质粒。与对照组相比,转染重组质粒后,survivin基因的表达明显降低,细胞凋亡率增加。转染前紫杉醇抑制A549细胞的IC50为转染后的11.9倍,两者比较,差异有显著性(P<0.05)。结论靶向survivin的shRNA能下调survivin基因表达,诱导细胞凋亡,增强A549细胞对紫杉醇的敏感性。Aim To construct the eukaryotic expression vectors of short hairpin RNA targeting survivin and observe its effect on biologic behavior of A549 cells and sensitivity of A549 cells to paclitaxel. Methods The DNA fragment targeting human survivin was inserted into the plasmid, and the recombinant plasmid was constructed. The recombinant plasmids cells were transfected into A549 cells by FuGENE transfection reagent. The expression levels of survivin gene were detected with RT-PCR and Western blot before and after transfection, respectively. Cell apoptosis was detected by TUNEL method. The sensitivity of A549 cells to paclitaxel was detected by MTT after transfection. Results The recombinant plasmid was successfully constructed. RNAi group cells showed lower expression of survivin than control group. The apoptosis rate of A549 cells increased after transfection. The IC50 of paclitaxel inhibiting A549 cells was 11.9 fold before transfection compared with those after transfection. There was significant difference between the two groups (P 〈 0. 05 ). Conclusion The shRNA targeting human survivin can down-regulate the expression of survivin, induce apoptosis, and enhance the sensitivity of A549 cells to paclitaxel.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222